Sign up to save your podcasts
Or
Share Episode 50 - Gemtesa, Enhertu, & Cabenuva
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 50 - Gemtesa, Enhertu, & Cabenuva
In today’s episode we'll be discussing the approval of Gemtesa for overactive bladder, and approval of an added indication of Enhertu for HER2 positive gastric cancer. We'll also go through the approval of a new monthly injectable product for HIV treatment. Don't forget to like, share, and subscribe! Enjoy!
View all episodes
By Ian Parnigoni PharmD.In today’s episode we'll be discussing the approval of Gemtesa for overactive bladder, and approval of an added indication of Enhertu for HER2 positive gastric cancer. We'll also go through the approval of a new monthly injectable product for HIV treatment. Don't forget to like, share, and subscribe! Enjoy!